June 14, 2024 · Form 4 insider transaction
BROWN MICHAEL S bought 1,535 shares of Regeneron Pharmaceuticals, Inc. at $625.60 per share, a transaction worth $960.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 26, 2024.